Jörg H W Distler

Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trial

Kristin B. Highland, Oliver Distler, Masataka Kuwana et al. · The Lancet Respiratory Medicine · 2021 · 212 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +8

Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study

Sébastien Peytrignet, Mark Lunt, Roger Hesselstrand et al. · Lara D. Veeken · 2017 · 76 citations · Full text

Medicine, Internal Medicine, Disability Management +16

Racial differences in systemic sclerosis disease presentation: a European Scleroderma Trials and Research group study

Veronika K. Jaeger, Mohammed Tikly, Dong Xu et al. · Lara D. Veeken · 2019 · 72 citations · Full text

Life Sciences, Biostatistics, Immunology +13

Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational Study

Ariane L. Herrick, Sébastien Peytrignet, Mark Lunt et al. · Annals of the Rheumatic Diseases · 2018 · 71 citations · Full text

Medicine, Clinical Sciences, Dermatology +15

Microparticles and Kawasaki disease: a marker of vascular damage?

Serena Guiducci, Eloisa Romano, Jörg H W Distler et al. · PubMed · 2011 · 15 citations

Medicine, Immunology, Pathology +14